RESUMEN
Collagen XVII (COL17) is a hemidesmosomal transmembrane protein in the skin, which, in several autoimmune blistering skin diseases, may be targeted by autoantibodies. In addition, loss-of-function mutations in the COL17A1 gene induce a subtype of junctional epidermolysis bullosa. The extracellular domain of COL17 can be physiologically cleaved from the cell surface by ADAM family proteins in a process known as ectodomain shedding. COL17 ectodomain shedding is thought to be associated with the migration and proliferation of keratinocytes. Furthermore, the C-terminal cleavage of COL17 may be associated with basement membrane formation. COL17 can be targeted by various proteases, including MMP9, neutrophil elastase, plasmin and granzyme B, which may be associated with blister formation in pemphigoid diseases. Interestingly, cleavage of COL17 may induce neoepitopes on the proteolysed fragments, and such induction is associated with dynamic structural changes. This review summarizes the current understanding of cleavage of COL17, and how such cleavage relates to blistering skin diseases.
Asunto(s)
Autoantígenos/genética , Enfermedades Autoinmunes/genética , Epidermólisis Ampollosa de la Unión/genética , Epidermólisis Ampollosa de la Unión/patología , Regulación de la Expresión Génica , Colágenos no Fibrilares/genética , Enfermedades Cutáneas Vesiculoampollosas/genética , Enfermedades Autoinmunes/inmunología , Vesícula/inmunología , Vesícula/patología , Epidermólisis Ampollosa de la Unión/inmunología , Femenino , Humanos , Incidencia , Masculino , Mutación/genética , Pronóstico , Enfermedades Raras , Medición de Riesgo , Enfermedades Cutáneas Vesiculoampollosas/inmunología , Colágeno Tipo XVIIAsunto(s)
Colágeno Tipo VII/inmunología , Epidermólisis Ampollosa/diagnóstico , Epidermólisis Ampollosa/inmunología , Queratina-14/inmunología , Queratina-5/inmunología , Anticuerpos/inmunología , Estudios Transversales , Epidermólisis Ampollosa Distrófica/diagnóstico , Epidermólisis Ampollosa Distrófica/inmunología , Epidermólisis Ampollosa Simple/diagnóstico , Epidermólisis Ampollosa Simple/inmunología , Epidermólisis Ampollosa de la Unión/diagnóstico , Epidermólisis Ampollosa de la Unión/inmunología , Técnica del Anticuerpo Fluorescente , HumanosRESUMEN
Recessive mutations in the LAMA3, LAMB3 and LAMC2 genes that encode laminin-332 (LM332) (α3a, ß3 and γ2 chains, respectively) cause different junctional epidermolysis bullosa (JEB) subtypes. Biallelic truncating mutations in any of these three genes usually lead to lack of protein expression resulting in the severe generalized JEB subtype, while missense or splice-site mutations in at least one allele lead to reduced expression typical of JEB generalized intermediate (JEB-gen intermed) or localized. Here, we molecularly characterized an adult patient with JEB showing negative skin staining for the anti-ß3 chain monoclonal antibody K140. This antibody recognizes an as yet unidentified epitope within the laminin ß3 short arm. The patient harbours a homozygous splice-site mutation resulting in highly aberrant transcripts with partial skipping of the LAMB3 exon that encodes the laminin epidermal growth factor-like motif 2 of the ß3 short arm (ß3-LE2). At the protein level, mutation consequences predict a misfolded ß3-LE2 motif and, indeed, we found that LM332 is correctly assembled but retained in the endoplasmic reticulum (ER) where it colocalizes with the lumenal ER chaperone protein BiP, leading to dramatically reduced secretion. Lack of K140 reactivity to mutant LM332 was confirmed by immunoprecipitation and Western blot analyses. Our findings not only identify the ß3-LE2 subdomain as the region recognized by K140, but also show that misfolding of LM332 structural motifs and subsequent protein retention in the ER is a common pathomechanism in JEB-gen intermed. In addition to its usefulness in antigen mapping diagnosis of JEB subtypes, this knowledge is relevant to the design of therapeutic strategies aimed at releasing ER-retained LM332 in JEB.
Asunto(s)
Epidermólisis Ampollosa de la Unión/inmunología , Queratinocitos/inmunología , Laminina/metabolismo , Adulto , Anticuerpos Monoclonales/metabolismo , Moléculas de Adhesión Celular/genética , Moléculas de Adhesión Celular/inmunología , Familia de Proteínas EGF/metabolismo , Epidermólisis Ampollosa de la Unión/genética , Humanos , Laminina/genética , Masculino , Mutación/genética , Sitios de Empalme de ARN/genética , KalininaAsunto(s)
Anticuerpos Monoclonales/inmunología , Autoantígenos/genética , Autoantígenos/inmunología , Epidermólisis Ampollosa de la Unión/diagnóstico , Colágenos no Fibrilares/genética , Colágenos no Fibrilares/inmunología , Epidermólisis Ampollosa de la Unión/genética , Epidermólisis Ampollosa de la Unión/inmunología , Humanos , Mutación , Colágeno Tipo XVIIRESUMEN
The tools for diagnosis of epidermolysis bullosa have advanced greatly since Hintner's group introduced antigen mapping as a diagnostic test for this family of genodermatoses. Monoclonal or polyclonal antibodies raised against some of the specific proteins found in the epidermis and basement membrane of the epidermis have allowed 4 types of epidermolysis bullosa de be identified and all variants to be classified. When a newborn baby presents with blisters, many conditions are implicated in the differential diagnosis. Examination under an optical microscope can suggest epidermolysis bullosa, but immunofluorescence mapping and electron microscopy are required for confirmation of the diagnosis and further classification of congenital epidermolysis bullosa. This article explains the importance of immunofluorescence antigen mapping and describes the methods employed for classification and subclassification of epidermolysis bullosa.
Asunto(s)
Epidermólisis Ampollosa/diagnóstico , Técnica del Anticuerpo Fluorescente Directa , Membrana Basal/inmunología , Biopsia , Diagnóstico Diferencial , Epidermis/inmunología , Epidermis/ultraestructura , Epidermólisis Ampollosa/clasificación , Epidermólisis Ampollosa/inmunología , Epidermólisis Ampollosa/patología , Epidermólisis Ampollosa Distrófica/diagnóstico , Epidermólisis Ampollosa Distrófica/inmunología , Epidermólisis Ampollosa Distrófica/patología , Epidermólisis Ampollosa Simple/diagnóstico , Epidermólisis Ampollosa Simple/inmunología , Epidermólisis Ampollosa Simple/patología , Epidermólisis Ampollosa de la Unión/diagnóstico , Epidermólisis Ampollosa de la Unión/inmunología , Epidermólisis Ampollosa de la Unión/patología , Humanos , Recién Nacido , Microscopía Fluorescente , Manejo de EspecímenesAsunto(s)
Autoantígenos/genética , Hipoplasia del Esmalte Dental/genética , Epidermólisis Ampollosa de la Unión/diagnóstico , Epidermólisis Ampollosa de la Unión/genética , Heterocigoto , Colágenos no Fibrilares/genética , Mapeo Cromosómico , Epidermólisis Ampollosa de la Unión/inmunología , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Recién Nacido , Masculino , Mutación/genética , Linaje , Estudios Retrospectivos , Colágeno Tipo XVIIRESUMEN
BACKGROUND: Mutations in the gene COL17A1 coding for type XVII collagen cause non-Herlitz junctional epidermolysis bullosa (nH-JEB). OBJECTIVES: Here we give an overview of the genotype-phenotype correlation in 12 patients from the Netherlands with type XVII collagen-deficient nH-JEB. PATIENT AND METHODS: Family and personal history and clinical presentation were recorded from each patient, and skin biopsies of intact and bullous skin were taken for immunofluorescence and electron microscopy. The mutations were identified by analysing the patient's DNA isolated from peripheral blood cells. RESULTS: DNA analysis identified five novel deletions: 1284delA, 1365delC, 3236delT, 3600-3601delCT and 4425delT. Interestingly, we identified a new patient, homozygous for 4425delT, with an exceptionally mild blistering phenotype. All together, three patients had more localized blistering confined to hands, lower legs and face, absent or very mild nail dystrophy, normal primary hair and sparse secondary hair. Nine patients had generalized blistering, nail dystrophy, sparse primary and absent secondary hair. All 12 patients had amelogenesis imperfecta (enamel pitting). Immunofluorescence (IF) antigen mapping with monoclonal antibodies 1A8C and 1D1 that bind to type XVII collagen, but not to its 97-kDa fragment was completely negative in patients with generalized blistering, whereas reduced in patients with localized blistering. CONCLUSIONS: Our data reveal that in patients with COL17A1 mutations a localized nH-JEB phenotype can be differentiated from a generalized nH-JEB phenotype by IF antigen mapping. The data are important for genetic counselling at early age when the clinical phenotype is not yet clear.
Asunto(s)
Autoantígenos/genética , Epidermólisis Ampollosa de la Unión/genética , Colágenos no Fibrilares/genética , Adulto , Anciano , Autoantígenos/inmunología , Vesícula/genética , Vesícula/inmunología , Niño , Preescolar , Epidermólisis Ampollosa de la Unión/inmunología , Femenino , Genotipo , Humanos , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Mutación , Países Bajos , Colágenos no Fibrilares/inmunología , Fenotipo , Turquía/etnología , Colágeno Tipo XVIIAsunto(s)
Antibacterianos/efectos adversos , Erupciones por Medicamentos/diagnóstico , Epidermólisis Ampollosa de la Unión/inducido químicamente , Inmunoglobulina A/metabolismo , Neumonía Estafilocócica/tratamiento farmacológico , Vancomicina/efectos adversos , Anciano , Antibacterianos/uso terapéutico , Biopsia , Complemento C3/metabolismo , Erupciones por Medicamentos/inmunología , Erupciones por Medicamentos/patología , Epidermólisis Ampollosa de la Unión/inmunología , Epidermólisis Ampollosa de la Unión/patología , Humanos , Masculino , Resistencia a la Meticilina , Piel/inmunología , Piel/patología , Vancomicina/uso terapéuticoRESUMEN
UNLABELLED: The term epidermolysis bullosa (EB) encompasses a heterogeneous group of genodermatoses, characterised by fragility and blistering of the skin, often associated with extracutaneous manifestations. The clinical picture comprises severe subtypes with lethal outcome in the first years of life as well as milder subtypes with localised blistering or minimal symptoms confined exclusively to nail or teeth abnormalities. We present the case of a male infant, who was born with a few bullae and rapidly developed extensive blistering of the skin. The disease was complicated by painful erosions of the oral mucosa, refused ingestion, and recurrent infections. The child died at the age of 4 months because of cardiac failure due to severe sepsis. Antigen mapping of a skin biopsy showed a split within the lamina lucida of the epidermal basement membrane zone and junctional epidermolysis bullosa (JEB) was diagnosed within the first 3 weeks of life. Markedly reduced staining for laminin 5 indicated the Herlitz type of JEB (OMIM 226700), which could be confirmed by mutation analysis in the LAMB3 gene, showing homozygous nonsense mutations. CONCLUSION: early antigen mapping using antibodies against the proteins affected in epidermolysis bullosa, is a useful tool providing early mutation analysis and valuable prognostic information needed for adequate therapeutic strategies. The recently published literature on current diagnostic procedures and the revised classification system for inherited epidermolysis bullosa aim towards a better understanding of the disease.
Asunto(s)
Epidermólisis Ampollosa de la Unión/genética , Membrana Basal/patología , Moléculas de Adhesión Celular/genética , Codón sin Sentido , Epidermólisis Ampollosa de la Unión/inmunología , Epidermólisis Ampollosa de la Unión/patología , Resultado Fatal , Femenino , Homocigoto , Humanos , Inmunohistoquímica , Recién Nacido , Análisis de Secuencia de ADN , KalininaRESUMEN
Recently, alpha6 integrin has been proposed as the epithelial cell receptor for papillomavirus. This study investigated whether alpha6 integrin is the cellular receptor for bovine papillomavirus type 4 (BPV-4), which is strictly epitheliotropic and infects the mucous epithelium of the upper digestive tract. Primary bovine mucosal keratinocytes from the palate of a foetus (PalK) displayed high levels of alpha6 integrin; matched primary fibroblasts from the same biopsy (PalF) expressed almost no alpha6 integrin. However, BPV-4 bound both PalK and PalF to similar, saturable levels. Native BPV-4 virions infected PalK in vitro, as detected by RT-PCR of E7 RNA. Infection could be blocked by excess virus-like particles (VLPs) and by neutralizing antisera against L1-L2 and L1 VLPs or by denaturation of the virions, supporting the view that infection in vitro mimics the process in vivo. alpha6 integrin-negative human keratinocyte cell lines were derived from patients affected by junctional epidermolysis bullosa presenting genetic lesions in their hemidesmosomes. The level of alpha6 integrin expression was determined in these cell lines by in situ immunofluorescence and FACS. Despite the absence of alpha6 integrin expression by BO-SV cells, they were bound by BPV-4 to similar, saturable levels as normal keratinocytes, KH-SV. Furthermore, BO-SV and KH-SV cells were both infected by BPV-4 to apparently the same extent as PalK cells. These results are consistent with the conclusion that alpha6 integrin is not the obligatory receptor for a bovine mucosotropic papillomavirus.
Asunto(s)
Antígenos CD/fisiología , Papillomavirus Bovino 1/patogenicidad , Receptores Virales/fisiología , Animales , Secuencia de Bases , Papillomavirus Bovino 1/genética , Papillomavirus Bovino 1/fisiología , Papillomavirus Bovino 4 , Bovinos , Línea Celular , Células Cultivadas , Cartilla de ADN/genética , Epidermólisis Ampollosa de la Unión/inmunología , Humanos , Integrina alfa6 , Queratinocitos/inmunología , Queratinocitos/virología , Papillomaviridae/patogenicidad , Papillomaviridae/fisiología , Infecciones por Papillomavirus/etiología , Infecciones Tumorales por Virus/etiologíaRESUMEN
BP180 is a member of the collagen protein family and is also referred to as type XVII collagen or BP antigen 2. It is a transmembrane protein constituent of the dermal-epidermal anchoring complex. The long-held hypothesis that BP180 functions as a cell-matrix adhesion molecule has been supported by recent investigations of human disorders of the dermal-epidermal junction in which BP180 is either genetically defective or targeted by the immune system. In generalized atrophic benign epidermolysis bullosa, mutations of BP180 result in an inherited subepidermal blistering disease. In bullous pemphigoid, herpes/pemphigoid gestationis, cicatricial pemphigoid, lichen planus pemphigoides and linear IgA disease, autoantibodies are directed to different epitopes on the BP180 ectodomain. Recent molecular investigations have provided new insights, not only into the mechanism of autoantibody-mediated subepidermal blistering, but also into the biochemical structure and cell biological functions of BP180 and other components of the dermal-epidermal anchoring complex. These findings have suggested new directions for the development of diagnostic and therapeutic tools for these autoimmune and genetic diseases.
Asunto(s)
Autoantígenos/inmunología , Proteínas Portadoras , Colágeno , Proteínas del Citoesqueleto , Epidermólisis Ampollosa de la Unión/inmunología , Proteínas del Tejido Nervioso , Colágenos no Fibrilares , Autoantígenos/genética , Autoantígenos/fisiología , Distonina , Epidermólisis Ampollosa de la Unión/genética , Humanos , Piel/inmunología , Piel/metabolismo , Piel/patología , Colágeno Tipo XVIIRESUMEN
Generalized atrophic benign epidermolysis bullosa (GABEB) is a rare variant of non-lethal junctional epidermolysis bullosa characterized by generalized skin blistering healing with atrophy and by atrophic alopecia with onset in childhood. Other features include mild mucosal blistering, dental abnormalities and nail dystrophy. We report four additional cases of GABEB from two families originating from the same isolated village. The patients shared an unusually mild clinical phenotype with cutaneous blisters strictly limited to trauma sites and rare occurrence of oral mucosal lesions. Scalp, eyelash and eyebrow alopecia was present in only two cases. Immunofluorescence studies showed a markedly reduced expression of the 180-kDa bullous pemphigoid antigen (BP180), and northern analysis of cultured keratinocytes indicated that the gene encoding for BP180 is affected in these GABEB patients.
Asunto(s)
Autoantígenos/análisis , Proteínas Portadoras , Colágeno , Proteínas del Citoesqueleto , Epidermólisis Ampollosa de la Unión/inmunología , Proteínas del Tejido Nervioso , Colágenos no Fibrilares , Adulto , Anciano , Distonina , Epidermólisis Ampollosa de la Unión/genética , Epidermólisis Ampollosa de la Unión/patología , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Piel/ultraestructura , Colágeno Tipo XVIIRESUMEN
We report the case of a 72-year-old man with clinical features resembling those of non-lethal junctional epidermolysis bullosa associated with IgG autoantibodies to the beta chain of laminin-5. The patient presented with a sudden onset of blistering and severe fragility of the skin and mucous membranes resulting in atrophic scars. Electron microscopy showed that the blistering arose in the lamina lucida. Indirect immunofluorescence indicated that the autoantibodies bound to the dermal side of 1 mol/L NaCl-split skin, and both direct and indirect immunoelectron microscopy demonstrated antibody binding to the lamina densa. Postembedding immunogold electron microscopy also revealed labelling in the lamina lucida beneath the hemidesmosomes. On immunoblotting, we found the autoantibodies to comigrate with the beta chain of laminin-5. Following the nomenclature of inherited junctional epidermolysis bullosa with mutations of the laminin-5 gene, we propose the name acquired junctional epidermolysis bullosa for this newly recognized disease.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Epidermólisis Ampollosa Adquirida/inmunología , Epidermólisis Ampollosa de la Unión/inmunología , Inmunoglobulina G/metabolismo , Laminina/inmunología , Anciano , Autoanticuerpos/metabolismo , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Immunoblotting , Laminina/química , Masculino , Microscopía InmunoelectrónicaRESUMEN
Junctional forms of epidermolysis bullosa (JEB) are characterized by tissue separation at the level of the lamina lucida. We have recently disclosed specific mutations in the LAMA3, LAMB3, and LAMC2 genes encoding the subunit polypeptides of the anchoring filament protein laminin 5 in 66 families with different variants of JEB. Examination of the JEB mutation database revealed recurrence of a particular C-->T substitution at nucleotide position 1903 (exon 14) of LAMB3, resulting in the mutation R635X. The inheritance of this nonsense mutation was noted on different genetic backgrounds, suggesting that R635X is a hotspot mutation. In this study, we have performed mutation evaluation in a European cohort of 14 families with the lethal, Herlitz type of JEB (H-JEB). The families were first screened for the presence of the R635X mutation by restriction enzyme digestion of the PCR product corresponding to exon 14. Four of the probands were found to be homozygous and six were heterozygous for R635X. The remaining alleles were subjected to mutation screening by PCR amplification of individual exons of LAMB3 and LAMC2, followed by heteroduplex analysis and nucleotide sequencing. In three families (six alleles), mutations in LAMC2 were disclosed. In the remaining eight alleles, additional pathogenetic LAMB3 mutations were found. None of the patients had LAMA3 mutation. Thus, LAMB3 mutations accounted for 22 of 28 JEB alleles (79%), and a total of 14 of 22 LAMB3 alleles (64%) harbored the R635X mutation, signifying its prevalence as a predominant genetic lesion underlying H-JEB in this European cohort of patients. This recurrent mutation will facilitate screening of additional JEB patients for the purpose of prenatal testing of fetuses at risk for recurrence.
Asunto(s)
Moléculas de Adhesión Celular/genética , Epidermólisis Ampollosa de la Unión/genética , Mutación , Antígenos/inmunología , Autoantígenos/inmunología , Moléculas de Adhesión Celular/inmunología , Análisis Mutacional de ADN , Epidermólisis Ampollosa de la Unión/inmunología , Epítopos/genética , Europa (Continente)/etnología , Técnica del Anticuerpo Fluorescente Directa , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Datos de Secuencia Molecular , Estudios Prospectivos , KalininaRESUMEN
We characterized basement membrane zone (BMZ) autoantigens targeted by autoantibodies (AAb) from patients with cicatricial pemphigoid. Serum from a patient with severe oral cicatricial pemphigoid contained IgG anti-BMZ AAb. The AAb labeled a lower BMZ component on salt-split skin and localized to the lower lamina lucida/lamina densa by direct and indirect immunoelectron microscopy (IEM) but did not label blood vessels. The AAb did not react with EHS laminin-1 and type IV collagen, pepsinized human type IV collagen, recombinant entactin, or NC1 domain of type VII collagen by dot blotting and western blotting. We focused our studies on the laminin family, as laminin-5 was identified as an autoantigen in cicatricial pemphigoid. Culture-conditioned media from normal keratinocytes (containing laminin-6 and laminin-5) and JEB keratinocytes (containing laminin-6 but not laminin-5) were studied by western blotting. Under nonreducing conditions, the patient's AAb recognized a 600-kDa protein (laminin-6) intensely and a 400-kDa protein (laminin-5) weakly in normal keratinocyte medium even though abundant laminin-5 was present. InJEB keratinocyte medium, however, the 600-kDa protein (laminin-6) alone was recognized by the patient's AAb. The AAb also immunolabeled BMZ of JEB skin that lacked laminin-5. The AAb from this patient and two other patients with anti-laminin-5 cicatricial pemphigoid immunoprecipitated both laminin-6 and laminin-5. Taken together, the results of IEM, non-reducing western blotting, immunoprecipitation, and JEB skin BMZ immunolabeling indicate that laminin-6, as well as laminin-5, is identified by the AAb from a subset of cicatricial pemphigoid patients. We propose the name "anti-laminin cicatricial pemphigoid" for this subset.
Asunto(s)
Autoanticuerpos/inmunología , Moléculas de Adhesión Celular/análisis , Moléculas de Adhesión Celular/inmunología , Laminina/análisis , Laminina/inmunología , Penfigoide Benigno de la Membrana Mucosa/inmunología , Adulto , Autoanticuerpos/análisis , Membrana Basal/química , Membrana Basal/inmunología , Membrana Basal/ultraestructura , Western Blotting , Moléculas de Adhesión Celular/metabolismo , Células Cultivadas , Colágeno/análisis , Colágeno/inmunología , Epidermólisis Ampollosa de la Unión/inmunología , Epidermólisis Ampollosa de la Unión/metabolismo , Epidermólisis Ampollosa de la Unión/patología , Femenino , Humanos , Queratinocitos/química , Queratinocitos/metabolismo , Queratinocitos/patología , Laminina/metabolismo , Microscopía Fluorescente , Microscopía Inmunoelectrónica , Penfigoide Benigno de la Membrana Mucosa/metabolismo , Penfigoide Benigno de la Membrana Mucosa/patología , Pruebas de Precipitina , Piel/química , Piel/citología , Piel/patología , KalininaRESUMEN
A full-term infant with junctional epidermolysis bullosa (JEB) is described. The distribution and morphologic characteristics of generalized blistering in areas of pressure in conjunction with perioral and perinasal granulation tissue suggested the diagnosis of generalized gravis (Herlitz) JEB. The family history was consistent with autosomal recessive inheritance. Electron microscopy demonstrated a subepidermal cleft arising in the lamina lucida with hemidesmosomal hypoplasia, findings consistent with gravis JEB. Immunofluorescent antigenic mapping localized laminin and type IV collagen exclusively to the blister base and weak reactivity of bullous pemphigold antigen to both the roof and the base. Type VII collagen (LH 7:2 epitope) was detected solely at the base of the cleavage plane, and abnormal staining of laminin 5 (kalinin, GB3, nicein) and 19-DEJ-1 antigen was observed. The patient died of sepsis at age 3 months. DNA extracted from cultured keratinocytes for molecular genetic analysis demonstrated a mutation with the LAMB3 gene encoding the beta 3 chain of laminin 5. We present the clinical and laboratory findings and briefly review recent advances in the diagnosis and management of JEB.
Asunto(s)
Epidermólisis Ampollosa de la Unión , Epidermólisis Ampollosa de la Unión/diagnóstico , Epidermólisis Ampollosa de la Unión/inmunología , Epidermólisis Ampollosa de la Unión/terapia , Humanos , Recién Nacido , Masculino , LinajeRESUMEN
Laminin 5 and laminin 6 are basement membrane proteins synthesized by the basal cells of stratifying squamous epithelia. Altered expression of laminin 5 has been associated with Herlitz junctional epidermolysis bullosa (H-JEB), a severe epidermal blistering disorder inherited as an autosomal recessive disease. We have isolated cDNA clones encoding the alpha 3 chain of laminin 5 and searched for mutations in the LAMA3 gene in H-JEB patients. In one H-JEB family, an affected individual exhibited drastically reduced immunoreactivity to antibodies directed against the alpha 3 chain of laminin 5 and an impaired expression of the corresponding mRNA transcripts. RT-PCR analysis of mRNA extracted from the proband's keratinocytes identified a homozygous single basepair deletion in the transcripts encoding the laminin alpha 3A and alpha 3B isoforms. The mutation causes a frameshift and premature termination codon in both alleles of the LAMA3 gene. Inheritance of the clinical H-JEB phenotype was consistent with the segregation of the mutated allele in the family. We also report the identity of the alpha chains of laminin 5 and epiligrin and provide evidence that LAMA3 transcripts are distinct from the laminin 6 alpha chain mRNA.
Asunto(s)
Epidermólisis Ampollosa de la Unión/genética , Homocigoto , Laminina/genética , Eliminación de Secuencia , Células 3T3 , Animales , Secuencia de Bases , Moléculas de Adhesión Celular/genética , Células Cultivadas , Clonación Molecular , Codón de Terminación , ADN Complementario , Epidermólisis Ampollosa de la Unión/inmunología , Femenino , Mutación del Sistema de Lectura , Humanos , Laminina/inmunología , Masculino , Ratones , Datos de Secuencia Molecular , Linaje , KalininaRESUMEN
Generalized atrophic benign epidermolysis bullosa (GABEB) is a form of nonlethal junctional epidermolysis bullosa characterized by universal alopecia and atrophy of the skin. We report a deficiency of the 180-kD bullous pemphigoid antigen in three patients with GABEB from unrelated families. We screened specimens of clinically normal skin from nine junctional epidermolysis bullosa patients (3 GABEB, 4 lethal, 1 cicatricial, 1 pretibial) by immunofluorescence using monoclonal antibodies to the 180-kD and 230-kD bullous pemphigoid antigens (BP180 and BP230). In the skin of the three GABEB patients there was no reactivity with antibodies to BP180, whereas staining for BP230 was normal. In the skin of the other six, non-GABEB patients, included in this study the expression of BP180 and BP230 was normal. Immunoblot analysis of cultured keratinocytes from one of the GABEB patients also failed to detect BP180 antigen, whereas BP230 was present in normal amounts. The deficient expression of BP180 is reflected in the RNA message, as in Northern blot analysis a reduced amount of BP180 transcripts, although of normal length, were detected. Interestingly, in another GABEB patient there were not-involved areas of skin, in which blistering could not be induced by rubbing. Biopsy material from these areas showed interrupted staining for BP180. There was no staining for BP180 in areas of clinically normal but involved skin of this patient. In conclusion, this study reveals that the BP180 antigen is deficient and the BP180 mRNA is reduced in generalized atrophic benign epidermolysis bullosa.
Asunto(s)
Autoantígenos/análisis , Proteínas Portadoras , Colágeno , Proteínas del Citoesqueleto , Epidermólisis Ampollosa de la Unión/inmunología , Proteínas del Tejido Nervioso , Colágenos no Fibrilares , Piel/inmunología , Adulto , Autoantígenos/genética , Membrana Basal/inmunología , Northern Blotting , Células Cultivadas , Distonina , Femenino , Técnica del Anticuerpo Fluorescente , Cabello/patología , Humanos , Immunoblotting , Queratinocitos/inmunología , Masculino , ARN Mensajero/análisis , Cuero Cabelludo/patología , Piel/patología , Piel/ultraestructura , Colágeno Tipo XVIIRESUMEN
NU-T2 antigen (Ag) is a new and recently described antigen of the dermal-epidermal junction, recognized by an anti-CD1b monoclonal antibody denominated NU-T2. We studied NU-T2 Ag expression in junctional epidermolysis bullosa (13 patients) and in other forms of hereditary epidermolysis bullosa (23 patients), comparing the results with nicein expression. In junctional epidermolysis bullosa gravis type no differences were found between the expression of NU-T2 and nicein, both being negative in bullous as well as in non-bullous skin. Interestingly, in mitis type junctional epidermolysis bullosa, NU-T2 Ag was found to be absent or reduced in five of six patients both in lesional and in uncleaved skin. When compared with nicein expression, clearcut differences were found, further suggesting that these two antigens are different. These data confirm that NU-T2 Ag is a novel epitope of the dermal-epidermal junction, probably relevant in dermal-epidermal cohesion, and it could be responsible, together with nicein, 19-DEJ-1 and other adhesion molecules, for the different subtypes of junctional epidermolysis bullosa. Finally, NU-T2 monoclonal antibody is a new relevant tool for the diagnosis, classification, and prenatal diagnosis of junctional epidermolysis bullosa.
Asunto(s)
Antígenos/inmunología , Epidermólisis Ampollosa de la Unión/inmunología , Piel/inmunología , Epidermis/inmunología , Epidermólisis Ampollosa Distrófica/inmunología , Epidermólisis Ampollosa Simple/inmunología , Técnica del Anticuerpo Fluorescente , HumanosRESUMEN
Integrin alpha 6 beta 4 is a major component of hemidesmosomes, considered to play a central role in the adhesion of basal epidermal cells to the underlying dermis. It is therefore of considerable interest in the study of the aetiology of inherited blistering disorders. We have examined the immunohistochemical characteristics of skin from 16 patients with epidermolysis bullosa using two antibodies directed against epitopes on the beta 4 subunit of alpha beta 4 integrin (G71, 3E1), one antibody directed against an epitope on the alpha 6 subunit (GoH3), GB3 an antibody for nicein, and LH7.2, an anticollagen type VII antibody. All 10 patients with junctional epidermolysis bullosa showed markedly reduced or no immunoreactivity with G71. These patients included two with GB3-positive junctional epidermolysis bullosa associated with pyloric atresia, and four with other subtypes. By contrast, five patients with dystrophic epidermolysis bullosa and one patient with epidermolysis bullosa simplex showed normal immunoreactivity with G71. In this study, G71 is shown to have a high specificity and sensitivity for the diagnosis of junctional epidermolysis bullosa. Immunoreactivity with 3E1 and GoH3 was normal in most patients, consistent with published reports showing normal immunoreactivity with other beta 4 and alpha 6 subunit antibodies. The data suggest a modification of the beta 4 subunit of integrin alpha 6 beta 4 at the dermo-epidermal junction in junctional epidermolysis bullosa.